Marker Therapeutics
MRKR
MRKR
11 hedge funds and large institutions have $1.14M invested in Marker Therapeutics in 2018 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
11
Holders Change
+3
Holders Change %
+37.5%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
BlackRock
New York
|
-$1.2K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Vanguard Group
Malvern,
Pennsylvania
| $455K | +$155K | +4,655 | +52% |
|
|
NRS
2
Neville Rodie & Shaw
New York
| $413K | – | – | – |
|
|
BFM
3
Boston Financial Management
Boston,
Massachusetts
| $206K | +$206K | +6,105 | New |
|
|
4
BlackRock
New York
| $47K | -$1.2K | -36 | -2% |
|
5
UBS Group
Zurich,
Switzerland
| $9K | +$1.41K | +44 | +19% |
|
|
HNB
6
Huntington National Bank
Columbus,
Ohio
| $2K | +$2K | +50 | New |
|
|
LTFS
7
Ladenburg Thalmann Financial Services
Miami,
Florida
| $2K | +$1.67K | +50 | +500% |
|
|
NSIM
8
North Star Investment Management
Chicago,
Illinois
| $1K | – | – | – |
|
|
AG
9
Advisor Group
Phoenix,
Arizona
| $1K | – | – | – |
|
10
Morgan Stanley
New York
| $1K | +$962 | +25 | +2,500% |
|